2023 ISPE Biotechnology Conference
Please Note:
- All full-access registration (virtual & in-person) includes access to speaker presentations, on-demand content, and other conference material.
- NOTE: Material is only available from those speakers/companies that permitted distribution.
- Registrants will receive email notification when the on-demand content is available.
- On-demand content is accessible for 90 days.
Thank you to all that made 2023 ISPE Biotechnology Conference such a big success!
Highlights: 2023 ISPE Biotechnology Conference
Featured Speakers
2023 ISPE Biotechnology Conference Gallery
Conference Highlights
-
iSpeak BlogWelcome fellow ISPE Bio Manufacturing members, sponsors, industry professionals, or those interested in the manufacturing of Cell and Gene Therapies! It is our pleasure to invite you to the 2023 ISPE Biotechnology Conference in Dublin, Ireland. In Track 3 of the conference, we will introduce you to the concept and commercialisation of ATMPs and cell and gene therapy.
-
iSpeak BlogFollowing the recent surge in popularity of mRNA technology due to Covid-19 vaccines, we are beginning to realise its impact and potential in this field and for oligonucleotides. However, we face a steep learning curve in understanding the diversity and specifics of the manufacturing chain that make this new generation of RNA drug products completely different from traditional biologics (e.g....
-
iSpeak BlogAre you interested in developing a new bioproduct and attracted by the incredible potentials of new modalities like ATMPs, Cell and Gene Therapies, AAVs, oligonucleotides, multi-specificity antibodies, mRNA vaccines, and more? Despite the appeal of these new modalities, there is a significant risk of failure due to the many unknowns associated with these new technologies.
-
iSpeak BlogSpeed to market is a major priority for life sciences companies and this is going to be a featured topic during the 2023 ISPE Biotechnology Conference. More than ever before, biotechnology companies are pushing for exponential growth by expediting the scalability of manufacturing processes and the use of different modalities. This can significantly accelerate patient access to life-saving...
-
iSpeak BlogThe advantages that come with a fully digitalized plant for manufacturing biopharmaceuticals are well documented and showcased throughout the biopharmaceutical industry and will be a featured topic during the 2023...
-
iSpeak BlogThe Biopharmaceutical industry continues to grow and deliver life-changing medicines to patients as evidenced by the number of drug approvals by the FDA year after year. In 2022 alone CDER approved 37 novel drugs, either as new molecular entities (NMEs) under New Drug Applications (NDAs) or as new therapeutic biological products under Biologics License Applications (BLAs). This has all been...